These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38344581)

  • 1. Euglycemic Diabetic Ketoacidosis Induced by Sodium-Glucose Cotransporter-2 Inhibitor Use and Coronary Angiography: A Case Report.
    VonTungeln CD; Al Bataineh M
    Cureus; 2024 Jan; 16(1):e52122. PubMed ID: 38344581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium-glucose Cotransporter-2 Inhibitors induced euglycemic diabetic ketoacidosis: A meta summary of case reports.
    Juneja D; Nasa P; Jain R; Singh O
    World J Diabetes; 2023 Aug; 14(8):1314-1322. PubMed ID: 37664476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Euglycemic Diabetic Ketoacidosis Precipitated by SGLT-2 Inhibitor Use, Pericarditis, and Fasting: A Case Report.
    Mendelsohn RA; Taveras AN; Mazer BA; Clayton LM
    Clin Pract Cases Emerg Med; 2020 Aug; 4(3):389-392. PubMed ID: 32926693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors - Lessons From a Case Series and Strategies to Decrease Incidence.
    Mehta PB; Robinson A; Burkhardt D; Rushakoff RJ
    Endocr Pract; 2022 Sep; 28(9):884-888. PubMed ID: 35753675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer Perspectives of Mechanisms for Euglycemic Diabetic Ketoacidosis.
    Yu X; Zhang S; Zhang L
    Int J Endocrinol; 2018; 2018():7074868. PubMed ID: 30369948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SGLT-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report and a Literature Review.
    Mahfooz RS; Khan MK; Al Hennawi H; Khedr A
    Cureus; 2022 Jun; 14(6):e26267. PubMed ID: 35911365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report.
    Alkatheeri A; Alseddeeqi E
    J Med Case Rep; 2022 Mar; 16(1):138. PubMed ID: 35346357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-surgical Euglycemic Diabetic Ketoacidosis in a Patient on Empagliflozin in the Intensive Care Unit.
    Bteich F; Daher G; Kapoor A; Charbek E; Kamel G
    Cureus; 2019 Apr; 11(4):e4496. PubMed ID: 31259114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapagliflozin-induced Late-onset Euglycemic Diabetic Ketoacidosis.
    Iqbal I; Hamid M; Khan MAA; Kainat A; Tariq S
    Cureus; 2019 Nov; 11(11):e6089. PubMed ID: 31857921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus.
    Chauhan S; Manov A; Dhillon GS; Shah P
    Cureus; 2023 Jan; 15(1):e33892. PubMed ID: 36819400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empagliflozin induced euglycemic diabetic ketoacidosis. A case reports.
    Altowayan WM
    Ann Med Surg (Lond); 2022 Dec; 84():104879. PubMed ID: 36582864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Unsuspected Case of Euglycemic Diabetic Ketoacidosis With Twists.
    Kang CY; Khamooshi P; Reyes Pinzon V
    Cureus; 2022 Apr; 14(4):e24016. PubMed ID: 35573514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors.
    Chow E; Clement S; Garg R
    BMJ Open Diabetes Res Care; 2023 Oct; 11(5):. PubMed ID: 37797963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Case of SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis.
    Rao SJ; Kumar K; Saleh N
    Cureus; 2022 Oct; 14(10):e30106. PubMed ID: 36381906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis.
    Patel K; Nair A
    Cureus; 2022 Sep; 14(9):e29652. PubMed ID: 36320965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Euglycemic diabetic ketoacidosis associated with ST segment elevation myocardial infarction following SGLT-2 inhibitor therapy.
    Baytuğan NZ; Çelik Aİ; Bezgin T; Çağdaş M
    Am J Emerg Med; 2023 Sep; 71():250.e1-250.e3. PubMed ID: 37451968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers.
    Somagutta MR; Agadi K; Hange N; Jain MS; Batti E; Emuze BO; Amos-Arowoshegbe EO; Popescu S; Hanan S; Kumar VR; Pormento K
    Cureus; 2021 Mar; 13(3):e13665. PubMed ID: 33824816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium-glucose cotransporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a patient with coronavirus disease 2019: a case report.
    Yii ESS; Azli AW; Sitaram PN
    J Med Case Rep; 2022 Jan; 16(1):17. PubMed ID: 34983625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: A case report.
    Lee IH; Ahn DJ
    Medicine (Baltimore); 2020 May; 99(21):e20228. PubMed ID: 32481295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-Induced Euglycemic Diabetic Ketoacidosis: When to Stop the Drip.
    Zughaib MT; Patel K; Leka M; Affas S
    Cureus; 2022 Jan; 14(1):e21768. PubMed ID: 35251838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.